Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR4879] to Cdc37 (phospho S13) (HRP)
- Suitable for: WB
- Reacts with: Human
- Conjugation: HRP
Product nameAnti-Cdc37 (phospho S13) antibody [EPR4879] (HRP)
See all Cdc37 primary antibodies
DescriptionRabbit monoclonal [EPR4879] to Cdc37 (phospho S13) (HRP)
Tested applicationsSuitable for: WBmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human Cdc37 (phospho S13). The exact sequence is proprietary.
- WB: HeLa whole cell lysate and HeLa whole cell lysate serum starved and treated with Calyculin A.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Stable for 12 months at -20°C. Store In the Dark.
Storage bufferpH: 7.40
Preservative: 0.1% 10% Proclin 300 Solution
Constituents: 30% Glycerol, PBS, 1% BSA
Concentration information loading...
PurityProtein A purified
Our Abpromise guarantee covers the use of ab202364 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/5000. Detects a band of approximately 44 kDa (predicted molecular weight: 44 kDa).|
FunctionCo-chaperone that binds to numerous kinases and promotes their interaction with the Hsp90 complex, resulting in stabilization and promotion of their activity.
Sequence similaritiesBelongs to the CDC37 family.
modificationsConstitutively sumoylated by UBE2I.
- Information by UniProt
- CDC 37 antibody
- Cdc37 antibody
- CDC37 cell division cycle 37 homolog antibody
All lanes : Anti-Cdc37 (phospho S13) antibody [EPR4879] (HRP) (ab202364) at 1/5000 dilution
Lane 1 : Untreated HeLa (Human epithelial carcinoma cell line) whole cell lysate
Lane 2 : HeLa (Human epithelial carcinoma cell line) whole cell lysate serum starved and Calyculin A treated
Lane 3 : HeLa (Human epithelial carcinoma cell line) whole cell lysate, serum starved and Calyculin A treated. The membrane was then incubated with Alkaline phosphatase.
Lysates/proteins at 10 µg per lane.
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 44 kDa
Observed band size: 44 kDa
Exposure time: 3 minutes
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab202864 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.
ab202364 has not yet been referenced specifically in any publications.